<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01628952</url>
  </required_header>
  <id_info>
    <org_study_id>PI2012_843_0007</org_study_id>
    <secondary_id>2012-000673-23</secondary_id>
    <nct_id>NCT01628952</nct_id>
  </id_info>
  <brief_title>Comparison of the Bilateral TAP Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study</brief_title>
  <official_title>Comparison of the Bilateral Transversus Abdominis Plane (TAP) Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Biomedical Research, prospective, randomized, controlled single-blind mono centric,
      phase IV comparison trial of the bilateral TAP block versus curare in muscle relaxation of
      the abdominal wall during laparoscopic digestive surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle relaxation.</measure>
    <time_frame>20 minutes after anesthesia induction</time_frame>
    <description>Muscle relaxation of the abdominal wall will be evaluated based on the amount of volume infused initially to create the pneumoperitoneum. This parameter is given by the unit of laparoscopy and allow us to calculate the abdominal compliance (C = ΔV / Ap).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>The Main of This Study is to Compare the Nerve Block of the Muscles of the Abdominal Wall Between the Bilateral TAP Block and Curare</condition>
  <arm_group>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>curare</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomized into two parallel groups. One group will receive curare, another benefit of a bilateral TAP block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transversus Abdominis Plane</intervention_name>
    <description>PIA coelioscopic</description>
    <arm_group_label>TAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curare</intervention_name>
    <description>IAP coelioscopic</description>
    <arm_group_label>curare</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years and under 75 years

          -  Informed consent signed

          -  ASA I, II and III

          -  Patient affiliated to social security

        Exclusion Criteria:

          -  ASA IV

               -  BMI&gt; 35 kg / m

               -  Personal or family history of malignant hyperthermia

               -  History of allergy or hypersensitivity to intravenous anesthetics (remifentanil),
                  local anesthetics or muscle relaxants

               -  Contraindications to sevoflurane: a history of malignant hyperthermia, history of
                  liver disease after sevoflurane anesthesia, halogenated agents or
                  hypersensitivity to any of these components.

               -  Contraindications to succinylcholine: hyperkalemia, plasma cholinesterase
                  deficiency nickname, para or tetraplegia more than 24 hours, burns over 24

               -  Contraindications to cisatracurium: myasthenia

               -  Neuromuscular diseases

               -  Contraindications to local anesthetics: hypersensitivity to local anesthetics of
                  the amide, intravenous regional anesthesia, porphyria, ventricular atrial
                  conduction disturbances, epilepsy uncontrolled by treatment

               -  Pregnancy and lactation

               -  severe coagulation disorders

               -  Inability to understand and give informed consent

               -  Patient under guardianship, curatorship or protected

               -  Indication of use of a hypnotic ketamine (BIS change)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé DUPONT, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>CHU Amiens France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>June 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2012</study_first_posted>
  <last_update_submitted>March 19, 2013</last_update_submitted>
  <last_update_submitted_qc>March 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curare</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

